Per CMS NCCI Policy Manual Chapter IV effective January 1, 2026, the same-joint arthroscopy bundling restriction for CPT codes 20600 through 20611 is an absolute restriction with no modifier override
In clinical trials, people taking tirzepatide for weight loss lost an average of about 21% of their starting body weight
The process as claimed in claims 1 and 4, wherein the peptide having amino acid sequence His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln- Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly has the formula His-Aib- Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu- Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-Resin wherein the amino acids of the sequence are optionally protected with protecting group(s)
What Changed Since October 2025
EndoC-H1 sublines were maintained in DMEM at 5 mM d-glucose supplemented with 2% BSA, 50 M -mercaptoethanol, 10 mM nicotinamide, 5.5 g ml 1 transferrin, 6.7 ng ml 1 sodium selenite, and 1% penicillin/streptomycin 40
April 2026: As of April 1, there are now 73 pending cases in MDL 3163, which involves vision loss (non-arteritic anterior ischemic optic neuropathy) cases filed by people taking GLP-1 drugs, including Zepbound
